JPMorgan Chase Financial Co. LLC has filed a new pricing supplement for $1.131 million in capped dual directional buffered equity notes. This filing, submitted on October 29, 2026, is significant as it showcases the company's ongoing efforts to expand its offerings in structured investments. The notes are linked to the performance of the Russell 2000 and S&P 500 indices, with a maximum upside return of 14%.
The filing indicates that JPMorgan Chase Financial Co. is positioning itself to attract investors seeking innovative investment products. The structured notes are designed to provide capped exposure to market appreciation while also offering protection against a certain level of depreciation. This strategy aligns with current trends in the national commercial banking sector, where banks are increasingly offering complex financial products to meet diverse investor needs.
Background
JPMorgan Chase Financial Co. LLC is a subsidiary of JPMorgan Chase & Co., a leading financial institution in the United States. The company operates under the Standard Industrial Classification (SIC) code 6021, which categorizes it as a national commercial bank. The firm is incorporated in Delaware and has its business address at 383 Madison Avenue, New York, NY.
Recent filings from the company include multiple 424B2 forms, all dated October 29, 2026, indicating a busy day for the firm in terms of regulatory submissions. The filings suggest a robust approach to capital management and investment strategy.
What the Filing Says
The pricing supplement details the structure of the notes, which are fully and unconditionally guaranteed by JPMorgan Chase & Co. The notes are designed for investors who are looking for capped, unleveraged exposure to the appreciation of the indices. The filing states:
"The notes are designed for investors who seek a capped, unleveraged exposure to any appreciation (with a Maximum Upside Return of 14.00%), or a capped, unleveraged return equal to the absolute value of any depreciation (up to the Buffer Amount of 10.00%)."
Investors should be aware that the notes are unsecured and subject to the credit risk of both JPMorgan Financial and JPMorgan Chase & Co. The filing emphasizes that any payment on the notes is contingent upon the performance of the underlying indices.
Impact
This development may affect a range of stakeholders, including investors looking for structured investment opportunities and competitors in the national commercial banking sector. The offering of these notes highlights JPMorgan's commitment to providing diverse financial products that cater to varying risk appetites and investment strategies.
What's Next
The filing does not specify what happens next, but it indicates that the notes priced on October 27, 2026, are expected to settle on or about October 30, 2026. Investors will be keen to monitor the performance of these notes as they become available in the market.
Read Next
Delta Air Lines officer files to sell 44,950 shares
Aspen Neuroscience reports major stock transactions by director
Aspen Neuroscience Reports Major Stock Transactions by Investors
John P. Reed files to sell 179,020 shares of Arhaus, Inc.
Webull Corp Officer Files to Sell 107,692 Shares
Fermi Inc. files to sell 94,000 shares of common stock










